Australia markets close in 3 hours 39 minutes

Samsung Biologics Co.,Ltd. (207940.KS)

KSE - KSE Delayed price. Currency in KRW
Add to watchlist
780,000.00-10,000.00 (-1.27%)
As of 11:13AM KST. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
895,297,714
857,691,298
798,056,210
393,589,468
240,974,800
Depreciation & amortisation
-
489,781,995
308,264,321
161,788,650
143,688,005
Change in working capital
-
298,743,499
-263,485,267
-234,840,497
-203,534,827
Inventory
-
-273,895,973
-179,912,330
-370,570,855
-184,885,326
Other working capital
-
560,903,858
-56,177,801
33,444,391
53,523,994
Other non-cash items
-
-15,215,398
11,200,069
4,747,012
2,745,267
Net cash provided by operating activities
-
1,666,228,521
953,047,810
454,596,217
202,090,027
Cash flows from investing activities
Investments in property, plant and equipment
-
-1,105,324,663
-1,009,225,611
-421,151,826
-148,566,033
Acquisitions, net
-18,101,000
-1,084,113,840
-1,097,331,081
-12,375,000
-
Purchases of investments
-
-7,849,562,951
-12,428,052,730
-5,840,000,000
-4,380,167,483
Sales/maturities of investments
-
8,465,729,712
11,427,889,761
5,340,000,000
4,110,000,000
Other investing activities
-
0.26
178,518
-0.01
-
Net cash used for investing activities
-
-1,566,305,450
-3,106,477,133
-933,489,191
-418,685,827
Net change in cash
-
-522,882,206
843,409,187
18,560,263
-96,250,533
Cash at beginning of period
-
890,819,571
47,410,384
28,850,121
125,100,653
Cash at end of period
-
367,937,365
890,819,571
47,410,384
28,850,121
Free cash flow
Operating cash flow
-
1,666,228,521
953,047,810
454,596,217
202,090,027
Capital expenditure
-
-1,105,324,663
-1,009,225,611
-421,151,826
-148,566,033
Free cash flow
-
560,903,858
-56,177,801
33,444,391
53,523,994